FDA Adverse Event Malfunction Summary report: N

NOVA STATSENSOR CREATININE HOSPITAL METER

MDR report key: 2506034 · Received March 22, 2012

Report

Report Number
1219029-2012-00001
Event Type
Malfunction
Date Received
March 22, 2012
Date of Event
March 12, 2012
Report Date
March 12, 2012
Manufacturer
NOVA BIOMEDICAL
Product Code
CGL
PMA / PMN Number
K070068
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

EVALUATION SUMMARY: THE INTERNAL INVESTIGATION ((B)(4)) TEST RESULTS SHOWED THAT THE RETAINS OF THE CUSTOMER CREATININE TEST STRIP LOT (LOT# 4911180249) MET THE DEFINED 510K CLEARANCE ACCEPTANCE CRITERIA FOR BOTH WHOLE BLOOD AND QUALITY CONTROL TESTING. THERE WERE NO OBVIOUS RESULT DISCREPANCIES OBSERVED AT ANY CREATININE LEVEL IN THE INVESTIGATION. IN SUMMARY, THE CUSTOMER COMPLAINT COULD NOT BE CONFIRMED. THAT INFORMATION WAS REPORTED TO THE INITIAL REPORTER.

Description of Event or Problem · 1

IT WAS DETERMINED BY THE HOSPITAL THAT A SINGLE NOVA STATSENSOR HOSPITAL METER CREATININE CAPILLARY PT RESULT WAS CLINICALLY SIGNIFICANTLY DIFFERENT THAN THE RESULT OBTAINED FROM A VENOUS SAMPLE FROM THE SAME PT ON THE HOSPITAL LABORATORY ANALYZER (SIEMEN ADVIA). PT; STATSENSOR RESULT: 0.75 MG/DL, LAB RESULT: 1.57 MG/DL. THE HOSPITAL THRESHOLD FOR THE ALLOWANCE OF THE ADMINISTRATION OF CONTRAST MEDIA IS A RESULT BELOW 1.50 MG/DL. THEREFORE THE PT WAS GIVEN CONTRAST MEDIA BASED ON THE RESULT FORM THE METER. PER THE REPORTER, THE PT WAS GIVEN IV SOLUTION TO DIFFUSE THE MEDIA AND WAS RELEASED TO GO HOME. AS OF THE DATE OF THIS REPORT, NO ADVERSE EFFECTS HAVE BEEN REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 NOVA STATSENSOR CREATININE HOSPITAL METER CGL - CREATININE TEST SYSTEM CGL NOVA BIOMEDICAL 43370 4911180249

Patients

Seq Age Sex Outcome Treatment
1 UNK Other